Laboratory analyses | VK group pre-treatment n = 129 | VK group post-treatment n = 129 | Trend VK group | p value VK group | Controls pre-treatment n = 129 | Controls post-treatment n = 129 | Trend controls | p value controls |
---|---|---|---|---|---|---|---|---|
PT-INR | 1.50 (1.40–1.60) | 1.40 (1.30–1.50) | ↓ | < 0.001 | 1.5 (1.4–1.6) | 1.4 (1.3–1.6) | ↓ | 0.004 |
APTT (s) | 35 (30–42) | 34 (30–42) | → | 0.96 | 36 (31–41) | 34 (30–41) | → | 0.41 |
Platelets (× 109/L) | 158 (121–224) | 150 (103–221) | ↓ | 0.008 | 167 (104–250) | 153 (99–209) | ↓ | < 0.001 |
Haemoglobin (g/L) | 102 (93–113) | 102 (94–112) | → | 0.19 | 108 (95–119) | 103 (94–116) | ↓ | 0.002 |
Fibrinogen (g/L) | 4 (2.9–4.6) | 4.6 (3.3–5.9) | ↑ | < 0.001 | 3.3 (2.3–4.9) | 3.8 (2.9–5.1) | ↑ | < 0.001 |
CRP (mg/L) | 146 (62–245) | 181 (106–278) | ↑ | < 0.001 | 89 (35–183) | 132 (61–232) | ↑ | < 0.001 |
Leukocytes (× 109/L) | 13 (9–18) | 13 (9–18) | → | 0.91 | 12 (8–17) | 11 (9–16) | → | 0.24 |